Delivery Order SPE2DR25D1202-SPE2DR26F73TA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,932.71 by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, and will be fulfilled at the company's Conshohocken facility. The award represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,732.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceutical product. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $29,007.77 by the Defense Logistics Agency on December 31, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of January 2, 2026. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $41,246.60 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $81,340.66 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $15,268.10 delivery order (Contract No. 4570236044) to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $17,662.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This non-competitive delivery order was issued on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens, with a ceiling value of $1,218.48. This competitively awarded, non-set-aside contract is classified as firm fixed price and was executed on January 5, 2026, with an ultimate completion date of January 6, 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $21,631.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors, with an ultimate completion date of November 17, 2025. This non-competitive delivery order was issued on November 14, 2025, to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. REPATHA (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency awarded a $18,738.83 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is the company's corporate headquarters in Conshohocken, Pennsylvania. REPATHA (evolocumab) is a PCSK9...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73TADelivery Order
On January 7, 2026, the Defense Logistics Agency awarded a $40,985.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. REPATHA (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible patient populations. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor serving federal military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA covering a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order represents one of numerous competitively awarded contracts through which AmerisourceBergen fulfills critical pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.0k | 1/6/26 |